ProSomnus Sleep Technologies, a pioneer in Smart Sleep Medicine, and MonitAir, a leading digital health and tele-monitoring platform for sleep medicine, have announced a collaboration to support connected, longitudinal, and personalized care for patients with Obstructive Sleep Apnea (OSA).
Integration Supports Remote Patient Monitoring
Through this collaboration, healthcare providers who prescribe a ProSomnus RPMO₂ OSA Device will be able to view, organize, and remotely monitor patient data within the MonitAir platform. The integration is designed to facilitate clinical visibility into patient status over multiple nights and to support coordination of care across clinical workflows.
Device and Platform Details
The FDA Class II cleared ProSomnus RPMO₂ OSA Device incorporates a pulse oximeter embedded into the buccal mucosal region of a maxillary dental overlay. It measures, displays, stores, and transmits oxygen saturation and pulse rate, and is designed for continuous data collection in clinical and home settings. The device has been validated against arterial oxygen saturation under controlled conditions, demonstrating accuracy across clinically relevant oxygenation ranges (Snow et al., 2025).
MonitAir's FDA-registered, HIPAA-compliant platform integrates remote physiologic monitoring (RPM), remote therapeutic monitoring (RTM), and chronic care management (CCM) capabilities into a unified workflow. It aggregates data from connected devices and provides tools for data visualization, compliance tracking, and communication, supporting clinicians in managing patients with sleep-related and respiratory conditions.
Enabling Personalized Care Through Integrated Monitoring
The collaboration aims to support personalized approaches to OSA management by collecting, monitoring, and displaying longitudinal physiologic data. Guidance from professional organizations such as the American Academy of Sleep Medicine (AASM) and the American Medical Association (AMA), along with evolving Centers for Medicare & Medicaid Services (CMS) policies, recognizes remote monitoring services as a mechanism to support ongoing management of chronic conditions through data collection, documentation, and structured patient engagement.
Within these frameworks, remote monitoring services may support:
- Longitudinal monitoring of patient status, including variability across nights and treatment periods.
- Structured documentation of remotely collected data.
- Patient engagement and communication through supported digital tools.
- Care coordination across stakeholders.
Executive Commentary
“Effectively managing Obstructive Sleep Apnea requires continuous, actionable insights, not just a single snapshot in time,” said Edward Mezerhane, MD, Chief Executive Officer of MonitAir. “By integrating the high-fidelity data from the ProSomnus RPMO₂ OSA Device directly into MonitAir’s comprehensive monitoring platform, we are giving clinicians the longitudinal visibility they need. This partnership bridges the critical gap between the patient’s home use and the provider’s clinical decision-making, empowering practices to optimize therapy, track compliance seamlessly, and deliver a higher standard of personalized care.”
